2
Outlines
• Concepts and economic evaluation methods
• Effectiveness measurement
• Cost measurement
• Cost-effectiveness analysis (CEA), Cost-Utility
analysis (CUA), Cost-benefit analysis (CBA),
Sensitivity analysis
3
Building blocks of health system
Information
and
evidence
Medical
Leadership
products
and
and
governance
technologies
Service
delivery
Health Health
financing workforce
4
• Medical products and technologies-equitable
access to essential medical products and
technologies of assured quality, safety, efficacy
and cost-effectiveness.
• Health financing-ensure people can use
needed services and are protected from
financial catastrophe or impoverishments
associated with having to pay for them.
5
• Health economics is a discipline that analyses
the economic aspects of health and health
care and that usually focuses on the costs
(inputs) and the consequences (outcomes) of
health care interventions using methods and
theories from economics and medicine.
Berger et al 2003.
• Economic evaluation is the comparative
analysis of alternative courses of action in
terms of both their costs and consequences.
Drummond et al 2005.
6
Economic evaluation (EE)
Lower Reject EE
(rare case)
EE_TP_theory.pptx 9 9
Economic, clinical and humanistic outcomes (ECHO model)
Technology
Pathogens Humanistic
Healthcare facilities
Health financing 10
Outcomes of Health Care
• Clinical outcomes;
mortality, morbidity, disability, clinical end points e.g.
blood pressure, serum glucose concentrations.
• Humanistic outcomes;
effects on physical, social, and emotional well-being
e.g. patient satisfaction, QALYs (Quality-adjusted life
years), DALY (Disability-adjusted life year).
• Economic outcomes;
impact on total health resource utilization and cost
e.g. savings (change) on treatment cost due to health
care intervention. EE_TP_theory.pptx 11
Cost of illness (CoI)
• CoI measures the economic burden of disease and
illness on society.
EE_TP_theory.pptx 12
Scope of the illness
Diabetes
EE_TP_theory.pptx
Hospitalizatio
Medical n, OPD visits,
cost lab, medical
Direct services
Transportation
cost , meal,
Non- accommodatio
Cost of Medical n, devices,
illness cost patient time
Indirect Work
due toabsence:
sick leave,
treatment,
cost disability,
EE_TP_theory.pptx informal care14
Costs in different perspectives
EE_TP_theory.pptx 15 15
Persons: Persons: illness
healthy/ risk -case avoided
Persons: Health KAP
-case detected
-success cases
Health Clinical
promotion CEA CEA intervention
-Diagnosis
Disease -Treatment
prevention/control -Rehabilitation
Persons: illness
CEA -case averted
-success case
Cost of healthcare -life year gained CEA Cost of
program -death averted Illness:
-DMC
CUA -DNMC
Persons: quality -IDC
KAP=knowledge, attitude, practice of life CUA
DMC=direct medical cost
DNMC=direct n0n-medical cost -QALY gained
IDC=indirect cost -DALY avoided
CoI=cost of illness
CEA=cost-effectiveness analysis
CUA=cost-utility analysis
CBA=cost-benefit analysis CBA Persons: illness CBA
-change on CoI 16
Study designs
• EE alongside RCT (piggyback study)
• EE using observational/ real world data
• EE using modeling designs
Decision tree model
Markov model
Dynamic model
• Combination designs
EE_TP_theory.pptx 17
Steps of CEA
Define the problem
Analyse
EE_TP_theory.pptx 19
Effectiveness measures
Clinical;
• Case averted (morbidity avoided)
• Successful case (eg controlling blood pressure,
sugar, cholesterol)
• Life year gained
• Life saved (death averted/ avoided)
Humanistic;
• Quality-Adjusted Life Year (QALY)
• Disability-Adjusted Life Year (DALY)
EE_TP_theory.pptx 20
Quality-Adjusted Life Year (QALY)
• is a universal health outcome measure combining
gains or losses in both quantity of life (mortality)
and quality of life (morbidity).
• Years adjusted by a preference-based quality
weight; utility score (full health =1, death=0, worse
than being dead = negative scores)
DALY =Years of life lost (YLL) + Years live with disability (YLD)
Berger et al 2003
EE_TP_theory.pptx 22
200 admitted cases + 1 death at 1year old
DALYs =Years of life lost (YLL)
+years lost due to disability (YLD)
Admitted cases =0.402x(5.83/365)x200
= 1.28 DALYS
Dead case = 71-1=70 DALYS
201 cases = 1.28 + 70 = 71.28 DALYs
• http://www.who.int/healthinfo/global_burden_di
sease/daly_disability_weight/en/index.html
EE_TP_theory.pptx 24
http://thaibod.net/diseases.html
EE_TP_theory.pptx 25
Calculation of ICER
Intervention Conventional
Cost ($) X1 X2
Life year gained (LYG) Y1 Y2
QALYs gained Q1 Q2
• ICER($/LYG) = X1 – X2
Y1 – Y2
• ICER ($/QALY) = X1 – X2
Q1 – Q2
EE_TP_theory.pptx 29
Cost-effectiveness plane
• A plot of incremental cost (Y axis) vs
incremental effect (X axis), slope is the ICER.
Source: http://europace.oxfordjournals.org/content/early/2008/12/20/europace.eun342/F1.expansion
EE_TP_theory.pptx 30
Ref: Wang et al 2009.
EE_TP_theory.pptx 31
Cost-Benefit Analysis
measures costs and benefits in monetary units
and computes a net pecuniary gain/loss.
Benefits: E2-E1
Costs; P
EE_TP_theory.pptx 33
References
1. Berger ML, Bingefors K, Hedblom EC, Pashos CL, Torrance GW. Health
care cost, quality, and outcomes. New Jersey: International Society
for Pharmacoeconomics and Outcome Research, 2003.
2. Briggs A, Sculpher M, Claxton K. Decision modelling for health
economic evaluation. New York: Oxford University Press, 2006.
3. Drummond M, McGuire A. Economic evaluation in health care:
merging theory with practice. Oxford: Oxford University Press 2001.
4. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL.
Methods for the economic evaluation of health care programmes
third edition. Oxford: Oxford University Press, 2005.
5. Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic evaluation in
clinical trials. Oxford: Oxford University Press, 2007.
6. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in
health and medicine. Oxford: Oxford University Press, 1996.
7. Muangchana C, Riewpaiboon A, Jiamsiri S, Thamapornpilas P,
Warinsatian P. Economic analysis for evidence-based policy-making
on a national immunization program: A case of rotavirus vaccine in
Thailand. Vaccine 2012 Apr 16;30(18):2839-47.
EE_TP_theory.pptx 34